Researcher profile · Semantic Scholar

F. Borellini

h-index: 10
Works: 26
Citations: 1,348

Most-cited papers

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.
J. Nemunaitis, D. Sterman, D. Jablons, John W. Smith +7 more
2004Journal of the National Cancer Institute241 citations
Semantic Scholar
Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer
E. Small, N. Sacks, J. Nemunaitis, W. Urba +9 more
2007Clinical Cancer Research237 citations
Semantic Scholar
Modulation of Transcription Factor Sp1 by cAMP-dependent Protein Kinase*
C. Rohlff, Shakeel Ahmad, F. Borellini, Jun-Yi Lei +1 more
1997Journal of Biological Chemistry223 citations Open access
Semantic Scholar
Growth control and differentiation in mammary epithelial cells.
F. Borellini, T. Oka
1989Environmental Health Perspectives136 citations Open access
Semantic Scholar
Phase I/II Trial of an Allogeneic Cellular Immunotherapy in Hormone-Naïve Prostate Cancer
J. Simons, M. Carducci, B. Mikhak, Michael Lim +8 more
2006Clinical Cancer Research127 citations Open access
Semantic Scholar
Plasmid DNA Malaria Vaccine: Tissue Distribution and Safety Studies in Mice and Rabbits
S. Parker, F. Borellini, M. Wenk, P. Hobart +4 more
1999Human Gene Therapy106 citations
Semantic Scholar
Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations.
P. Escarpe, N. Zayek, Peggy S. Chin, F. Borellini +3 more
2003Molecular Therapy91 citations Open access
Semantic Scholar
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects
P. Anton, R. Mitsuyasu, S. Deeks, D. Scadden +8 more
2003AIDS (London)89 citations Open access
Semantic Scholar
Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 leukemia cells
F. Borellini, A. Aquino, S. Josephs, R. Glazer
1990Molecular and Cellular Biology38 citations Open access
Semantic Scholar
Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses
P. Working, A. Lin, F. Borellini
2005Oncogene32 citations
Semantic Scholar
Phase I/II Trial of an Allogeneic Cellular Immunotherapy in Hormone-NaI« ve Prostate Cancer
J. Simons, M. Carducci, B. Mikhak, Michael Lim +8 more
20068 citations
Semantic Scholar
Adenovirus Reference Materials: Determination of Particle Concentrations Obtained by Orthogonal, Physical-Chemical Methods
E. Lehmberg, P. Shabram, T. Schluep, Shu Wen +11 more
20035 citations
Semantic Scholar
Report from the Lentivirus Vector Working Group: Issues for Developing Assays and Reference Materials for Detecting Replication-Competent Lentivirus in Production Lots of Lentivirus Vectors
Keith L. Carson, V. Kiermer, F. Borellini, Xiaobin Lu +9 more
20054 citations
Semantic Scholar
The Transfer of Technology from the Laboratory to the Clinic: In Process Controls and Final Product Testing
F. Borellini, J. Ostrove
20014 citations
Semantic Scholar
A Phase 1/11 trial of IV CG7870, a replication-selective, PSA-targeted oncolytic adenovirus (OAV), for the treatment of hormone-refractory, metastatic prostate cancer
G. Wilding, M. Carducci, D.-C. Yu, J. Burke +5 more
20043 citations
Semantic Scholar
Analysis for loss of heterozygosity (LOH) of p53 allele in tumors derived from p53+/− and CD‐1 mice following repeated subcutaneous injections of solutions containing antioxidants
A. Youssef, F. Borellini, D. Jacobson-Kram, F. Fort
2001Environmental and Molecular Mutagenesis3 citations
Semantic Scholar
BRIEF COMMUNICATION Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non- Small-Cell Lung Cancer
J. Nemunaitis, D. Sterman, D. Jablons, John W. Smith +5 more
20041 citations
Semantic Scholar
Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus is accompanied by nuclear accumulation of the tumor suppressor p53.
F. Borellini, R. Glazer, L. Kopelovich
1996International Journal of Oncology1 citations
Semantic Scholar
330 INVITED The Development of Vemurafenib for BRAF-mutated, Metastatic Melanoma
F. Borellini
20110 citations
Semantic Scholar
Assays for the Release of Viral Vector Gene Therapy Products for Human Clinical Trials
F. Borellini
20070 citations
Semantic Scholar
Metastatic Prostate Cancer Patients Treated With GVAX?? Vaccine for Prostate Cancer Develop Immunoreactivity to Filamin: Role of Filamin in Prostate Cancer Metastasis
M. Chinnappa, Laurie Wong, J. Aimi, D. Denagel +3 more
20050 citations
Semantic Scholar
Characterization of autologous and allogeneic tumour cells.
F. Borellini
2004Developments in Biologicals0 citations
Semantic Scholar
A Phase 1/11 trial of IV CG7870, a replication-selective, PSA-targeted oncolytic adenovirus (OAV), for the treatment of hormone-refractory, metastatic prostate cancer.
G. Wilding, M. Carducci, D.-C. Yu, J. Burke +6 more
2004Journal of Clinical Oncology0 citations
Semantic Scholar
897. The development of standards for cell and gene therapy products: The activities of the United States pharmacopeia
F. Borellini, S. Seaver, I. Deveau, B. Hutchins
20040 citations Open access
Semantic Scholar
Increased activity of SP1 and NFkB transcriptional enhancer elements in adriamycin-resistant HL-60 (HL-60/AR) leukemia cells
F. Borellini, A. Aquino, S. Josephs, R. Glazer
19900 citations
Semantic Scholar
Increased Expression andDNA-Binding Activity ofTranscription Factor SplinDoxorubicin-Resistant HL-60Leukemia Cells
F. Borellini, A. Aquino, I. Robert
19900 citations
Semantic Scholar

J. Nemunaitis

×3

E. Small×3

J. Simons×3

A. Aquino×3

J. Aimi×3

D. Sterman×2

D. Jablons×2

John W. Smith×2